M&A Deal Summary |
|
|---|---|
| Date | 2020-08-19 |
| Target | ProMedica |
| Sector | Healthcare Services |
| Buyer(s) | Genesis Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 225M EUR |
| Size | Small |
| Type | Sector Agnostic |
Genesis Capital SRO is a private equity firm specializing in buyouts (MBOs, MBIs, LBO) and growth capital investments in small and mid-sized enterprises throughout the Czech Republic and Slovakia. Genesis looks to commit €2 to €9 million of equity per transaction (more with co-investors). Genesis generally targets proven businesses with growth potential and strong management. Areas of interest includes processing industry products, commercial services, energy, technology, specialized chemicals, construction materials, healthcare, leisure, selected security equipment and specialty retail. Genesis will not invest in real estate, firearms, gambling, adult entertainment, tobacco or alcohol. Genesis Capital SRO was formed in 1999 and is based in Czech Republic.
| DEAL STATS | # |
|---|---|
| Overall | 40 of 56 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 27 of 40 |
| State: District of Columbia M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-06 |
R2B2
Prague, Czech Republic R2B2 is a programmatic advertising company, operating a cross-platform digital ad network across computers, mobile devices, and TVs. It helps publishers monetize inventory and enables advertisers to reach audiences, serving 100+ publishers and TV stations with access to hundreds of agencies and direct advertisers. R2B2 was founded in 2014 and is based in Prague, Czech Republic. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-30 |
Quinta-Analytica
Praha, Czech Republic Quinta-Analytica is a provider of commercial services for the pharmaceutical, biotechnology and generic drug industries as a contract research organisation. Quinta-Analytica was founded in 1997 and is based in Praha, Czech Republic. |
Sell | - |